Ascendis Pharma A/S banner

Wall St Price Targets

ASND Price Forecast
Based on 24 analysts

+22% Upside
from $267.07 today

Ascendis Pharma A/S (ASND)’s 12-month stock price forecast through November 2027 has a consensus target of $325.38, implying 22% upside. The forecast is based on price targets from 24 Wall Street analysts.

ASND Analyst Rating
Based on 21 analysts

avg. 4.67 of 5
Strong buy
15 71%
Buy
5 24%
Hold
1 5%
Sell
0 0%
Strong sell
0 0%

Analysts rate ASND Strong buy, with 20 of 21 recommending Buy or Strong buy.

Ascendis Pharma A/S Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is ASND's stock price target?
Price Target
325.38 USD

According to Wall Street analysts, the average 1-year price target for ASND is 325.38 USD with a low forecast of 270.68 USD and a high forecast of 361.2 USD.

What is the Revenue forecast for Ascendis Pharma A/S?
Projected CAGR
25%

Over the last 12 years, the compound annual growth rate for Revenue has been 35%. The projected CAGR for the next 8 years is 25%.

What is the Gross Profit forecast for Ascendis Pharma A/S?
Projected CAGR
26%

The compound annual growth rate for Gross Profit over the next 8 years is 26%.

Back to Top